Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.37 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.37 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.37 |
| ▸ | ITGAL | P20701 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 6/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | CRHBP | P24387 | 2/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7039789 | 0.78 | PKM (0.42) | PKMTSHRLMNAALDH1A1KDM4E | |
| SCHEMBL11845341 | 0.74 | PKM (0.42) | PKMTSHRLMNAALDH1A1KDM4E | |
| SCHEMBL294469 | 0.74 | TSHR (0.42) | PKMTSHRLMNAALDH1A1KDM4E | |
| SCHEMBL294470 | 0.74 | PKM (0.42) | PKMTSHRLMNAKMT2AABCG2 | |
| SCHEMBL30218838 | 0.74 | PKM (0.42) | PKMTSHRLMNAALDH1A1KDM4E | |
| SCHEMBL276292 | 0.74 | PKM (0.47) | PKMTSHRLMNAKMT2AABCG2 | |
| SCHEMBL29474944 | 0.74 | PKM (0.42) | PKMTSHRLMNAKMT2AABCG2 | |
| SCHEMBL5541737 | 0.74 | PKM (0.42) | PKMTSHRLMNAALDH1A1KDM4E | |
| SCHEMBL2009018 | 0.74 | PKM (0.42) | PKMTSHRLMNAALDH1A1KDM4E | |
| SCHEMBL9724429 | 0.74 | PKM (0.38) | PKMTSHRLMNAALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119708875-A | Mitochondrial DNA targeted 4-aminobenzopyran photosensitive dye and preparation method and application thereof | 河南师范大学 | 2025-03-28 | — | — | CN | claimed |
| CN-119708875-B | Mitochondrial DNA targeted 4-aminobenzopyran photosensitive dye and preparation method and application thereof | 河南师范大学 | 2026-03-17 | — | — | CN | disclosed |
| CN-119708875-B | Mitochondrial DNA targeted 4-aminobenzopyran photosensitive dye and preparation method and application thereof | 河南师范大学 | 2026-03-17 | — | — | CN | disclosed |
| CN-119708875-A | Mitochondrial DNA targeted 4-aminobenzopyran photosensitive dye and preparation method and application thereof | 河南师范大学 | 2025-03-28 | — | — | CN | disclosed |
| CN-119708875-A | Mitochondrial DNA targeted 4-aminobenzopyran photosensitive dye and preparation method and application thereof | 河南师范大学 | 2025-03-28 | — | — | CN | disclosed |
| CN-119708875-A | Mitochondrial DNA targeted 4-aminobenzopyran photosensitive dye and preparation method and application thereof | 河南师范大学 | 2025-03-28 | — | — | CN | disclosed |
| CN-107266345-B | (hetero) arylcyclopropylamine compounds as LSD1 inhibitors | 奥瑞泽恩基因组学股份有限公司 | 2021-08-17 | — | — | CN | disclosed |
| EP-3736265-A1 | (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | Oryzon Genomics, S.A. (ES) | 2020-11-11 | — | — | EP | disclosed |
| EP-2768805-B1 | (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | ORYZON GENOMICS SA (ES) | 2020-03-25 | — | — | EP | disclosed |
| US-10329256-B2 | (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors | ORYZON GENOMICS, S.A. (ES) | 2019-06-25 | — | — | US | disclosed |
| CN-1250536-C | 4-aminobenzopyran derivatives | NISSAN CHEMICAL IND LTD (JP) | 2006-04-12 | — | — | CN | disclosed |
| WO-2005090357-A1 | TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-09-29 | — | — | WO | disclosed |
| US-6809114-B2 | ANTIARRHYTHMIC AGENTS; SUCH AS 6-ACETYLAMINO-3,4-DIHYDRO-2,2-DIMETHYL-7-NITRO-4-N-PENTYLAMINO-2H-1 -BENZOPYRAN-3-OL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2004-10-26 | — | — | US | disclosed |
| CN-1529702-A | 4-aminobenzopyran derivatives | �ղ���ѧ��ҵ��ʽ���� | 2004-09-15 | — | — | CN | disclosed |
| CN-1529702-A | 4-aminobenzopyran derivatives | �ղ���ѧ��ҵ��ʽ���� | 2004-09-15 | — | — | CN | disclosed |
| CN-1520406-A | Antiarrhythmic substituted benzopyran derivatives | �ղ���ѧ��ҵ��ʽ���� | 2004-08-11 | — | — | CN | disclosed |
| US-20040068002-A1 | 4-aminobenzopyran derivatives | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2004-04-08 | — | — | US | disclosed |
| EP-0412760-B1 | Benzopyran derivatives | BEECHAM GROUP PLC (GB) | 1994-11-23 | — | — | EP | disclosed |
| EP-0566567-A1 | ANTIHYPERTENSIVE BENZOPYRAN DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1993-10-27 | — | — | EP | disclosed |
| EP-0412760-A2 | Benzopyran derivatives | Beecham Group p.l.c. (GB) | 1991-02-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040068002-A1 | 4-aminobenzopyran derivatives | CYP2D6, KCNH1, CYP2B6 | PKM 1437/4885TSHR 2947/4885LMNA 2906/4885 |
| US-10329256-B2 | (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors | KDM1B, KDM1A, KDM2A | PKM 920/4885TSHR 4274/4885LMNA 2909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.